Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 28, Issue 9, Pages 2283-2287Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gft236
Keywords
alpha-Klotho; analytical validation; immunoassays; standardization
Categories
Funding
- Dutch Kidney Foundation [CP10.11]
Ask authors/readers for more resources
Background. alpha-Klotho is a protein mainly produced in the kidney. Its circulating form has been suggested to link renal damage and distant tissue pathology. As three assays to measure alpha-Klotho became commercially available, we performed an evaluation of these commercially available Klotho assays. Methods. We studied within-run variation, between-run variation, matrix effects, linearity, and recovery of added recombinant human Klotho in the alpha-Klotho assays of IBL (IBL International GmbH, Hamburg, Germany), Cusabio (Cusabio Biotech, Wuhan, China) and USCN (USCN life Science, Inc., Wuhan, China) using both serum and ethylenediaminetetraacetic acid plasma. Results. Within run variation was 4, 13 and 32% for the IBL, Cusabio and USCN assay, respectively. Agreement between serum and EDTA plasma was good in the IBL assay, but poor in the USCN and Cusabio assays however improved after modifications in the Cusabio assay. Standardization and agreement between assays was poor. Conclusions. The commercially available methods for the measurement of alpha-Klotho differ in quality. Some of the manufacturers should improve their assays in order to produce accurate results so that reliable conclusions can be drawn from studies in which these assays are used.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available